ExploreWatchlistsPricing
  1. JP-listed companies
  2. ONO PHARMACEUTICAL CO., LTD.
  3. Financials
  4. Operating expenses

ONO PHARMACEUTICAL CO., LTD. (4528)

Market cap
¥1.2T
P/E ratio
16.9x
Japanese pharmaceutical company that develops, manufactures and sells prescription and over-the-counter drugs through a global network of 26 subsidiaries.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndOperating expenses (Million JPY)YoY (%)
Mar 31, 2025125,671+25.33%
Mar 31, 2024100,270+12.05%
Mar 31, 202389,486+16.13%
Mar 31, 202277,057+11.31%
Mar 31, 202169,230+2.29%
Mar 31, 202067,679-3.36%
Mar 31, 201970,033-54.03%
Mar 31, 2018152,355+14.97%
Mar 31, 2017132,515+39.18%
Mar 31, 201695,212+10.11%
Mar 31, 201586,468

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat